{'fraction_non_alphanumeric': 0.030952380952380953, 'fraction_numerical': 0.02219047619047619, 'mean_word_length': 5.166177334116266, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland

Abstract Objectives This study aimed to investigate the faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in Switzerland and to genetically characterize the isolates. Methods A total of 399 stool samples from healthy individuals employed in different food-processing plants were cultured on a selective medium containing 10 mg/L florfenicol. Resulting enterococci were screened by PCR for the presence of cfr, optrA and poxtA. A hybrid approach combining short-read and long-read WGS was used to analyse the genetic context of the cfr, optrA and poxtA genes. Results Enterococcus faecalis (n = 6), Enterococcus faecium (n = 6), Enterococcus gallinarum (n = 1) and Enterococcus hirae (n = 2) were detected in 15/399 (3.8%) of the faecal samples. They carried cfr + poxtA, optrA, optrA + poxtA or poxtA. Four E. faecalis harbouring optrA and one E. faecium carrying poxtA were resistant to linezolid (8 mg/L). In most optrA-positive isolates, the genetic environments of optrA were highly variable, but often resembled previously described platforms. In most poxtA-positive isolates, the poxtA gene was flanked on both sides by IS1216E elements and located on medium-sized plasmids. Conclusions Faecal carriage of Enterococcus spp. harbouring cfr, optrA and poxtA in healthy humans associated with the food-production industry demonstrates the possibility of spread of oxazolidinone resistance genes into the community. Given the importance of linezolid as a last-resort antibiotic for the treatment of serious infections caused by Gram-positive pathogens, the detection of the oxazolidinone resistance determinants in enterococci from healthy humans is of concern for public health.


Introduction
The oxazolidinone antibiotic linezolid is one of the most important treatment options for severe infections caused by Gram-positive pathogens. In enterococci, linezolid resistance mechanisms include mutations in domain V of the 23S rRNA binding site and the acquisition of the transferable genes cfr, optrA or poxtA. 1 Although linezolid-resistant enterococci (LRE) are reported globally at very low percentages (<1%), 2,3 there remains cause for concern in view of possible horizontal gene transfer and dissemination of LRE within hospital environments.
Beyond the clinical setting, LRE have been detected throughout the agricultural sector, where they are co-selected by the use of florfenicol, a fluorinated derivative of chloramphenicol. 4 Notably, optrA has been found frequently in isolates of animal origin, suggesting the possibility of foodborne transmission of this resistance determinant to humans. 5 With currently few reports on human colonization with optrA-carrying enterococci, 6,7 data on faecal carriage of enterococci harbouring oxazolidinone resistance genes in healthy humans remain scarce. Therefore, this study was designed to: (i) assess faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy individuals in Switzerland; (ii) characterize the isolates; and (iii) investigate the genetic context of the linezolid resistance determinants.

Sampling and identification of enterococci harbouring oxazolidinone resistance genes
A total of 399 stool samples were obtained during September 2021 by the National Centre for Enteropathogenic Bacteria and Listeria (NENT) during a yearly routine Salmonellae screening of employees of a large foodprocessing company. This company consists of 10 countrywide processing plants and employs people from the surrounding urban communities. The study was approved by the local ethics committee of Zürich, Switzerland (BASEC-Nr.Req-2016-00374) and did not require participants' consent.
Samples were processed and the presence of cfr-like genes, optrA and poxtA in enterococcal isolates was established by singleplex PCR as described previously. 8

WGS and genome analysis
Whole genomes were determined using short-read sequencing (Illumina MiniSeq, Illumina, San Diego, CA, USA). Isolates for which the genetic environment of cfr, optrA or poxtA could not be resolved from short-read data were additionally long-read sequenced on a MinION Mk1B device (Oxford Nanopore Technologies, Oxford, UK). Bacterial DNA extraction and sequencing, read assembly and in silico analyses are detailed in the Supplementary Materials and methods (available as Supplementary data at JAC Online).

Nucleotide accession numbers
Sequencing data and genome assemblies are available under BioProject no. PRJNA783264. Assembly accession numbers are listed in Table S1 (available as Supplementary data at JAC Online).

Isolation of enterococci harbouring oxazolidinone resistance determinants
Overall, 15 enterococci harbouring oxazolidinone resistance genes were retrieved from 399 samples, corresponding to a faecal carriage rate of 3.8%. A total of nine isolates harboured optrA alone (n = 6) or in combination with poxtA (n = 3), corresponding to an overall faecal carriage rate of optrA-positive enterococci of 2.3%. Nine isolates carried poxtA alone or in combination with cfr (n = 1) or with optrA (n = 3), corresponding to an overall faecal carriage rate of poxtA-positive enterococci of 2.3%.

Identification of cfr, optrA and poxtA variants
For the optrA-harbouring enterococci, nucleotide sequences were compared with the WT optrA E349 (GenBank accession number KP399637) 10 and variants were defined based on alterations in the deduced amino acid sequences. A total of seven OptrA variants (including the WT) were identified (Table S1). They corresponded to OptrA E349 , the EDM variant, 6 identical at nucleotide level to that from E. faecalis E016 (GenBank accession no. KT862781), 11 the EDD variant, 6 corresponding to the gene from E. faecalis G20 (GenBank accession no. KT862784), 11 the DP_2 variant, 1 identical to that from E. faecalis 10-2-2 (GenBank accession no. KT862775), 11 and the KLDP variant. 6 Two novel OptrA variants, EDD_2 and EYNKWKVDASKELYNKQLEIG, respectively, were identified. The OptrA variants and their amino acid substitutions are listed in Table S2.

Genetic environment of optrA variants
As shown in Figure 1, the genetic environments of optrA were highly variable in the different isolates; however, they often resembled those described previously: in Enterococcus hirae 211a and E. faecium 264a, optrA was found on a shared platform that was associated with Tn558 (tnpA-tnpB-tnpC-orf138-fexA) integrated into the chromosomal radC gene, as found in swine and human isolates elsewhere. 11,14 See Figure 1. Similarly, in E. faecium 642, the optrA-containing platform consisted of the Tn558-associated genes and the araC-optrA module and was integrated at the radC site as described for aquatic Enterococcus raffinosus. 15 See Figure 1. E. faecalis 661 harboured an impB-fexA-optrA segment on a 25 kb plasmid previously described in porcine E. faecalis. 11 See Figure 1. A similar environment was identified in the 38 kb plasmid of E. faecalis 732, differing, however, in the genes located downstream of optrA (Figure 1).

Genetic environment of poxtA variants
In most poxtA-positive isolates, poxtA was flanked on both sides by IS1216E elements located near fexB (

Discussion
In this study we found a faecal carriage rate of optrA-positive enterococci of 2.3%, which is lower than the 3.5% reported in a comparable study in healthy humans in China. 6 Notably, there is a lack of comparative data on the presence of poxtA-harbouring enterococci in healthy humans. However, one of the few available studies reported a prevalence of 1%. 18 With a prevalence of poxtA of 2.3%, our data suggest that optrA and poxtA occur with equal frequency among enterococci in healthy humans living in the community. However, it must be noted that these findings apply primarily to individuals with occupational exposure to food and may therefore not be directly generalized to the entire community.
Phenotypic resistance to linezolid was observed for E. faecalis carrying OptrA E349 , the DP_2 variant and the KLDP variant. In all cases, the resistance determinants were plasmid encoded and represented the simplest versions of optrA contexts described in this study. A comparison with other isolates harbouring identical optrA platforms showed that resistance levels to linezolid may vary. For example, in isolate 661, the optrA region was identical to that found in linezolid-susceptible porcine E. faecalis 10-2-2 from China. 11   identical to that found in susceptible E. faecium 1521 from this study. Thus, it is interesting that linezolid MIC levels may vary substantially despite a common resistance determinant within identical genetic environments. Further, the finding of optrA and poxtA in genetic contexts identical to those found in human and animal enterococci in different geographical regions suggests the occurrence of independent genetic events linked to IS1216E and Tn558-like elements, and to plasmids belonging to repA_N or other replicon families. Likewise, various E. faecalis and E. faecium STs identified in this study have been described in clinical and animal settings worldwide. For instance, optrA-positive E. faecalis ST16 (CC16) has been identified among clinical isolates in China, Greece and Denmark, and in pigs and poultry in Korea. 1,19 Further, optrA-positive E. faecalis ST32 (CC4) and optrA-positive E. faecium ST29 (CC17) have been described in pigs and poultry in Korea and China. 19 Recently, optrA-positive E. faecalis ST40 (CC40) and optrA + poxtA-positive E. faecalis ST1008 were detected in raw meat-based pet food in Portugal. 20 The occurrence of these STs in healthy individuals highlights their potential to spread between animals and humans, with implications for public health.

Conclusions
This study provides novel insight into the role of the healthy human gut as a reservoir of cfr-, optrA-and poxtA-positive enterococci. The occurrence of enterococci harbouring clinically relevant oxazolidinone resistance determinants in genetic environments that have been described in clinical isolates as well as in livestock-associated settings worldwide is of epidemiological interest. Regular and updated information on the occurrence of oxazolidinone resistance genes in enterococcal isolates is essential to anticipate future trends in the prevalence and dissemination of cfr, optrA and poxtA.